{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:26:09Z","timestamp":1779290769503,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00508-009-1149-z","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T10:24:18Z","timestamp":1246011858000},"source":"Crossref","is-referenced-by-count":10,"title":["Parathyroid hormone-dependent hypercalcemia","Parathormon-abh\u00e4ngige Hyperkalz\u00e4mie"],"prefix":"10.1007","volume":"121","author":[{"given":"Judit","family":"T\u0151ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Pat\u00f3cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Gergics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"Stenczer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1roly","family":"R\u00e1cz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikl\u00f3s","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,1]]},"reference":[{"issue":"Suppl 2","key":"1149_CR1","first-page":"N12","volume":"17","author":"LJ Melton 3rd","year":"2002","unstructured":"Melton LJ, 3rd (2002) The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res 17 [Suppl 2]: N12\u201317","journal-title":"J Bone Miner Res"},{"key":"1149_CR2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0895-4356(00)00239-0","volume":"53","author":"R Jorde","year":"2000","unstructured":"Jorde R, Bonaa KH, Sundsfjord J (2000) Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidemiol 53: 1164\u20131169","journal-title":"J Clin Epidemiol"},{"key":"1149_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.1992.tb00540.x","volume":"231","author":"A Sorva","year":"1992","unstructured":"Sorva A, Valvanne J, Tilvis RS (1992) Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years. J Intern Med 231: 309\u2013312","journal-title":"J Intern Med"},{"issue":"Suppl 2","key":"1149_CR4","first-page":"N18","volume":"17","author":"S Adami","year":"2002","unstructured":"Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17 [Suppl 2]: N18\u201323","journal-title":"J Bone Miner Res"},{"key":"1149_CR5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF02067385","volume":"16","author":"B Niederle","year":"1992","unstructured":"Niederle B, Stamm L, Langle F, Schubert E, Woloszczuk W, Prager R (1992) Primary hyperparathyroidism in Austria: results of an 8-year prospective study. World J Surg 16: 777\u2013782","journal-title":"World J Surg"},{"key":"1149_CR6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00268-005-0239-y","volume":"30","author":"N Ozbey","year":"2002","unstructured":"Ozbey N, Erbil Y, Ademo\u011flu E, Ozarma\u011fan S, Barbaros U, Bozbora A (2002) Correlations between vitamin D status and biochemical\/clinical and pathological parameters in primary hyperparathyroidism. World J Surg 30: 321\u2013326","journal-title":"World J Surg"},{"key":"1149_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1026508829397","volume":"1","author":"JP Bilezikian","year":"2000","unstructured":"Bilezikian JP, Silverberg SJ (2000) Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord 1: 237\u2013245","journal-title":"Rev Endocr Metab Disord"},{"issue":"Suppl 2","key":"1149_CR8","first-page":"N37","volume":"17","author":"SJ Marx","year":"2002","unstructured":"Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, et al (2002) Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 17 [Suppl 2]: N37\u201343","journal-title":"J Bone Miner Res"},{"key":"1149_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","volume":"71","author":"EM Brown","year":"1991","unstructured":"Brown EM (1991) Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 71: 371\u2013411","journal-title":"Physiol Rev"},{"key":"1149_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","volume":"81","author":"EM Brown","year":"2001","unstructured":"Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239\u2013297","journal-title":"Physiol Rev"},{"key":"1149_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","volume":"366","author":"EM Brown","year":"1993","unstructured":"Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, et al (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366: 575\u2013580","journal-title":"Nature"},{"key":"1149_CR12","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1074\/jbc.270.21.12919","volume":"270","author":"JE Garrett","year":"1995","unstructured":"Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, et al (1995) Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270: 12919\u201312925","journal-title":"J Biol Chem"},{"key":"1149_CR13","first-page":"759","volume":"378","author":"N Chattopadhyay","year":"1997","unstructured":"Chattopadhyay N, Vassilev PM, Brown EM (1997) Calcium-sensing receptor: roles in and beyond systemic calcium homeostasis. Biol Chem 378: 759\u2013768","journal-title":"Biol Chem"},{"key":"1149_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10408360590886606","volume":"42","author":"J Tfelt-Hansen","year":"2005","unstructured":"Tfelt-Hansen J, Brown EM (2005) The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 42: 35\u201370","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1149_CR15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1210\/jcem-67-5-944","volume":"67","author":"GA Brent","year":"1988","unstructured":"Brent GA, LeBoff MS, Seely EW, Conlin PR, Brown EM (1988) Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab 67: 944\u2013950","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1149_CR16","first-page":"N30","volume":"17","author":"A Arnold","year":"2002","unstructured":"Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, et al (2002) Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res 17 [Suppl 2]: N30\u2013 36","journal-title":"J Bone Miner Res"},{"key":"1149_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(98)06434-4","volume":"353","author":"DE Cole","year":"1999","unstructured":"Cole DE, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, et al (1999) A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 353: 112\u2013115","journal-title":"Lancet"},{"key":"1149_CR18","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1210\/jc.2004-0129","volume":"89","author":"A Scillitani","year":"2004","unstructured":"Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, et al (2004) Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 89: 5634\u20135638","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/eje.0.1450421","volume":"145","author":"S Miedlich","year":"2001","unstructured":"Miedlich S, Lamesch P, Mueller A, Paschke R (2001) Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism. Eur J Endocrinol 145: 421\u2013427","journal-title":"Eur J Endocrinol"},{"key":"1149_CR20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/BF03345085","volume":"25","author":"F Cetani","year":"2002","unstructured":"Cetani F, Borsari S, Vignali E, Pardi E, Picone A, Cianferotti L, et al (2002) Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism. J Endocrinol Invest 25: 614\u2013619","journal-title":"J Endocrinol Invest"},{"key":"1149_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2006-0857","volume":"92","author":"A Scillitani","year":"2007","unstructured":"Scillitani A, Guarnieri V, Battista C, De Geronimo S, Muscarella LA, Chiodini I, et al (2007) Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. J Clin Endocrinol Metab 92: 277\u2013283","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/eje.1.02286","volume":"155","author":"S Corbetta","year":"2006","unstructured":"Corbetta S, Eller-Vainicher C, Filopanti M, Saeli P, Vezzoli G, Arcidiacono T, et al (2006) R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur J Endocrinol 155: 687\u2013692","journal-title":"Eur J Endocrinol"},{"key":"1149_CR23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0167-4889(88)90014-6","volume":"968","author":"P Nygren","year":"1988","unstructured":"Nygren P, Gylfe E, Larsson R, Johansson H, Juhlin C, Klareskoq L, et al (1988) Modulation of the Ca2+-sensing function of parathyroid cells in vitro and in hyperparathyroidism. Biochim Biophys Acta 968: 253\u2013260","journal-title":"Biochim Biophys Acta"},{"key":"1149_CR24","first-page":"715","volume":"76","author":"S Khosla","year":"1993","unstructured":"Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath H 3rd (1993) Calcium infusion suggests a \"set-point\" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76: 715\u2013720","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1149_CR25","first-page":"N24","volume":"17","author":"EM Brown","year":"2002","unstructured":"Brown EM (2002) The pathophysiology of primary hyperparathyroidism. J Bone Miner Res 17 [Suppl 2]: N24\u201329","journal-title":"J Bone Miner Res"},{"key":"1149_CR26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2265.2003.t01-1-01755.x","volume":"59","author":"S Miedlich","year":"2003","unstructured":"Miedlich S, Lamesch P, Mueller A, Paschke R (2003) Update on genetic and clinical aspects of primary hyperparathyroidism. Clin Endocrinol (Oxf) 59: 539\u2013554","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1149_CR27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2000.00933.x","volume":"52","author":"S Corbetta","year":"2000","unstructured":"Corbetta S, Mantovani G, Lania A, Borgato S, Vicentini L, Beretta E, et al (2000) Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia. Clin Endocrinol (Oxf) 52: 339\u201348","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1149_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2006.07.003","volume":"89","author":"N Chattopadhyay","year":"2006","unstructured":"Chattopadhyay N, Brown EM (2006) Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 89: 189\u2013202","journal-title":"Mol Genet Metab"},{"key":"1149_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","volume":"41","author":"J Warner","year":"2004","unstructured":"Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, et al (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications J Med Genet 41: 155\u2013160","journal-title":"J Med Genet"},{"key":"1149_CR30","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/jmg.2005.035766","volume":"43","author":"JV Warner","year":"2006","unstructured":"Warner JV, Nyholt DR, Busfield F, Epstein M, Burgess J, Stranks S, et al (2006) Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. J Med Genet 43: e12","journal-title":"J Med Genet"},{"key":"1149_CR31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-3476(72)80232-4","volume":"81","author":"TP Foley Jr","year":"1972","unstructured":"Foley TP Jr, Harrison HC, Arnaud CD, Harrison HE (1972) Familial benign hypercalcemia. J Pediatr 81: 1060\u20131067","journal-title":"J Pediatr"},{"key":"1149_CR32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","volume":"75","author":"MR Pollak","year":"1993","unstructured":"Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, et al (1993) Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297\u20131303","journal-title":"Cell"},{"key":"1149_CR33","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1074\/jbc.271.32.19537","volume":"271","author":"M Bai","year":"1996","unstructured":"Bai M, Quinn S, Trivedi S, Kifor O, Pearce SH, Pollak MR, et al (1996) Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem 271: 19537\u201319545","journal-title":"J Biol Chem"},{"key":"1149_CR34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/0004563042466802","volume":"41","author":"IR Gunn","year":"2004","unstructured":"Gunn IR, Gaffney D (2004) Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review. Ann Clin Biochem 41: 441\u2013458","journal-title":"Ann Clin Biochem"},{"key":"1149_CR35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002230001201","volume":"68","author":"J Hinnie","year":"2001","unstructured":"Hinnie J, Bell E, McKillop E, Gallacher S (2001) The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 68: 216\u2013218","journal-title":"Calcif Tissue Int"},{"key":"1149_CR36","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2007-0322","volume":"92","author":"PH Nissen","year":"2007","unstructured":"Nissen PH, Christensen SE, Heickendorff L, Brixen K, Mosekilde L (2007) Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab 92: 4373\u20134379","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR37","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2265.2006.02512.x","volume":"64","author":"BK Ward","year":"2006","unstructured":"Ward BK, Magno AL, Blitvich BJ, Rea AJ, Stuckey BG, Walsh JP, et al (2006) Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia. Clin Endocrinol (Oxf) 64: 580\u2013587","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1149_CR38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2265.1999.00788.x","volume":"50","author":"S Pearce","year":"1999","unstructured":"Pearce S, Steinmann B (1999) Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism. Clin Endocrinol (Oxf) 50: 691\u2013693","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1149_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(85)90455-3","volume":"78","author":"SJ Marx","year":"1985","unstructured":"Marx SJ, Fraser D, Rapoport A (1985) Familial hypocalciuric hypercalcaemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes. Am J Med 78: 15\u201322","journal-title":"Am J Med"},{"key":"1149_CR40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2007.02896.x","volume":"67","author":"J Toke","year":"2007","unstructured":"Toke J, Czirjak G, Patocs A, Enyedi B, Gergics P, Csakvary V, et al (2007) Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene. Clin Endocrinol (Oxf) 67: 385\u2013392","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1149_CR41","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1172\/JCI118335","volume":"96","author":"SH Pearce","year":"1995","unstructured":"Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, et al (1995) Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96: 2683\u20132692","journal-title":"J Clin Invest"},{"key":"1149_CR42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI119137","volume":"99","author":"M Bai","year":"1997","unstructured":"Bai M, Pearce SH, Kifor O, Trivedi S, Stauffer UG, Thakker RV, et al (1997) In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99: 88\u201396","journal-title":"J Clin Invest"},{"key":"1149_CR43","first-page":"2347","volume":"147","author":"J Horanyi","year":"2006","unstructured":"Horanyi J, Szlavik R, Duffek L, Darvas K, Gyorke T, Lakatos P, et al (2006) Surgery of primary hyperparathyroidism. Orv Hetil 147: 2347\u20132351","journal-title":"Orv Hetil"},{"key":"1149_CR44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2265.2007.02953.x","volume":"67","author":"K Balogh","year":"2007","unstructured":"Balogh K, Hunyady L, Patocs A, Gergics P, Valkusz Z, Toth M, et al (2007) MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 67: 727\u2013734","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1149_CR45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00508-006-0635-9","volume":"118","author":"A Patocs","year":"2006","unstructured":"Patocs A, Klein I, Szilvasi A, Gergics P, Toth M, Valkusz Z, et al (2006) Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer. Wien Klin Wochenschr 118: 417\u2013421","journal-title":"Wien Klin Wochenschr"},{"key":"1149_CR46","first-page":"129","volume":"62","author":"J Toke","year":"2007","unstructured":"Toke J, Toth M, Patocs A, Bertalan R, Gergics P, Stenczer B, et al (2007) Analysis of calcium-sensing gene mutations in Hungarian patients. Magy Belorv Arch 62: 129\u2013134","journal-title":"Magy Belorv Arch"},{"key":"1149_CR47","first-page":"1","volume":"8","author":"National Institutes of Health Consensus Development Conference","year":"1990","unstructured":"National Institutes of Health Consensus Development Conference (1990) Diagnosis and management of asymptomatic primary hyperparathyroidism. Consens Statement 8: 1\u201318","journal-title":"Consens Statement"},{"key":"1149_CR48","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Potts JT Jr, Fuleihan GE-H, Kleerekoper M, Neer R, Peacock M, et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87: 5353\u20135361","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR49","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1210\/jc.2008-1305","volume":"93","author":"GE Fuleihan","year":"2008","unstructured":"Fuleihan GE (2008) Hyperparathyroidism: Time to reconsider current clinical decision paradigms. J Clin Endocrinol Metab 93: 3302\u20133304","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4158\/EP.11.1.49","volume":"11","author":"AACE\/AAES Task Force on Primary Hyperparathyroidism","year":"2005","unstructured":"AACE\/AAES Task Force on Primary Hyperparathyroidism (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11: 49\u201354","journal-title":"Endocr Pract"},{"key":"1149_CR51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","volume":"140","author":"LA Lambert","year":"2005","unstructured":"Lambert LA, Shapiro SE, Lee JE, Perrier ND, Truong M, Wallace MJ, et al (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140: 374\u2013382","journal-title":"Arch Surg"},{"key":"1149_CR52","first-page":"258","volume":"114","author":"K Kaczirek","year":"2002","unstructured":"Kaczirek K, Prager G, Schindl M, Kaserer K, Gessl A, Vierhapper H, et al (2002) Multiple endocrine neoplasia 1 \u2013 current recommendations for diagnosis and treatment. Wien Klin Wochenschr 114: 258\u2013266","journal-title":"Wien Klin Wochenschr"},{"key":"1149_CR53","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11864-006-0042-5","volume":"7","author":"LH VanderWalde","year":"2006","unstructured":"VanderWalde LH, Haigh PI (2006) Surgical approach to the patient with familial hyperparathyroidism. Curr Treat Options Oncol 7: 326\u2013333","journal-title":"Curr Treat Options Oncol"},{"key":"1149_CR54","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/jc.2004-1155","volume":"90","author":"P Ferolla","year":"2005","unstructured":"Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, et al (2005) Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 90: 2603\u20132609","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR55","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658\u20135671","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR56","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2796.2003.01166.x","volume":"253","author":"MS Cohen","year":"2003","unstructured":"Cohen MS, Moley JF (2003) Surgical treatment of medullary thyroid carcinoma. J Intern Med 253: 616\u2013626","journal-title":"J Intern Med"},{"key":"1149_CR57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","volume":"257","author":"T Carling","year":"2005","unstructured":"Carling T, Udelsman R (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257: 27\u201337","journal-title":"J Intern Med"},{"key":"1149_CR58","first-page":"2042","volume":"85","author":"T Carling","year":"2000","unstructured":"Carling T, Szabo E, Bai M, Ridefelt P, Westin G, Gustavsson P, et al (2000) Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85: 2042\u20132047","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1149-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-009-1149-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1149-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:53:17Z","timestamp":1559094797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-009-1149-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":58,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s00508-009-1149-z","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]},"article-number":"236"}}